Clinical outcome following reinjection of Ranibizumab for reactivation of retinopathy of prematurity.

Autor: Bassiouny RM; Lecturer of Ophthalmology, Department of Ophthalmology, Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt. raniabassiouny@mans.edu.eg., Gaafar WM; Associate Professor of Ophthalmology, Department of Ophthalmology, Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt., El Nokrashy A; Lecturer of Ophthalmology, Department of Ophthalmology, Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Abdelhameed AG; Associate Professor of Ophthalmology, Department of Ophthalmology, Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Attallah EA; Assistant Lecturer of Ophthalmology, Department of Ophthalmology, Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Elgharieb AG; Assistant Lecturer of Ophthalmology, Department of Ophthalmology, Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Bassiouny MR; Professor of Pediatrics, Department of Pediatrics, Mansoura University Children Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Publikováno v: Eye (London, England) [Eye (Lond)] 2022 Nov; Vol. 36 (11), pp. 2137-2143. Date of Electronic Publication: 2021 Oct 28.